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Colin P. Smith, Derk-Jan Dijk and Simon N. Archer
Thepowerof theapplicationofbioinformaticsacrossmultiple
publicly available transcriptomic data sets was explored.
Using 19 human and mouse circadian transcriptomic data
sets, we found thatNR1D1 andNR1D2which encode heme-
responsive nuclear receptors are the most rhythmic tran-
scripts across sleep conditions and tissues suggesting that
they are at the core of circadian rhythmgeneration. Analyzes
of human transcriptomic data show that a core set of
transcripts related to processes including immune function,
glucocorticoidsignalling,and lipidmetabolismisrhythmically
expressed independently of the sleep-wake cycle. We also
identify key transcripts associated with transcription and
translation that are disrupted by sleep manipulations, and
through network analysis identify putative mechanisms
underlying the adverse health outcomes associated with
sleep disruption, such as diabetes and cancer. Comparative
bioinformaticsappliedtoexistingandfuturedatasetswillbea
powerful tool for the identification of core circadian- and
sleep-dependent molecules.
Keywords:.bioinformatics; clock gene; gene expression; Reverb;
sleep disruption
: Additional supporting information may be found in theonline version of this article at the publisher’s web-site.
Introduction
The advent of high-resolution high-throughput technologies
has enabled the simultaneous measurement of mRNA levels
for all genes within a mammalian system under particular
conditions. Several groups interested in mammalian circadian
rhythms have now used these technologies to identify genes
that are expressed rhythmically during ‘‘normal’’ (i.e.
controlled conditions that bear some similarity to habitual
conditions) and ‘‘perturbed’’ conditions (e.g. the forced
desynchronisation of the sleep-wake cycle and central clock
in the brain, forced wakefulness, removal of the light/dark
cycle, manipulations of scheduled feeding times) in species
including human and mouse (e.g. [1–9]). Clearly, as each
research group performs the most suitable experiment to test
their own hypotheses, there are large differences in protocols
(perturbations), the type of sample taken (tissue, blood etc.),
the resolution of sampling times, the numbers of subjects,
technological platforms, and the analytical algorithms used to
identify rhythmic signals. This variability across experiments
can be a significant obstacle in the comparative analysis of
gene specific responses across conditions and/or mammalian
systems. However, the variability across experiments can also
be exploited to address specific research questions from a
slightlydifferentperspective. Forexample, ifwewere to identify
a set of genes that are expressed rhythmically across multiple
experiments from different organisms, experimental set-ups,
laboratories, and statistical analyses, then those genes, by the
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very nature of their identification, could be classified as ‘‘robust
rhythmic genes.’’While this list of robust genes is likely to be an
under-estimation, due to the cross-comparison of different data
sets, thresholds etc., we speculate that such genes are most
likely tobe closely associatedwith the core circadianmachinery
of mammalian systems.
In this paper we report a comparative analysis of circadian
genes (i.e. genes with a circadian expression profile) identified
from two human gene expression datasets that comprise four
conditions: 40hours of total sleep deprivation (TSD) following
sufficient sleep (8.5hours per night), and 40hours of TSD
following insufficient sleep (5.7 hours per night) [7], and
sleeping either in phasewithmelatonin, amarker of the central
hypothalamic clock and biological night, or sleeping 12hours
out of phase with melatonin [2]. We first identified genes
that were circadian in these human in vivo experiments. To
further investigate the robustness of these circadian genes, we
compared them with genes that were identified as circadian
in cultured human bone cells [4], human hair follicles [1], post-
mortem human brain tissue [5], in brain and liver from two
mouse sleep deprivation studies [3, 6], and multiple tissue
expression datasets frommice [8, 9]. This approach identified a
core set of mainly human-blood specific rhythmic genes across
sleep conditions, some core circadian clock genes that were
generally rhythmic across all samples, and several core clock
genes that appear to be differentially rhythmic between human
or mouse samples. Further bioinformatic analysis determined:
which manipulations of the sleep-wake cycle impacted most
upon circadian rhythmicity; the genes affected by disrupted
sleep; and the underlying processes with potential links to
associated adverse health conditions.
Congruency of human rhythmic gene
expression signals
Amultitude of biochemical and physiological pathways exhibit
daily changes in function. These rhythms are driven in part by
environmental cycles and behavioral cycles, as well as by
endogenous, self-sustaining circadian oscillators found
throughout thevariousorgansand tissuesof thebody, including
blood cells. The predominant molecular model of the clock
describes a set of interlocking transcriptional-translational
feedback loops. In the core loop, CLOCK (and in some tissues
NPAS2) and BMAL1 proteins stimulate transcription of three
PERIOD (PER) and two CRYPTOCHROME (CRY) genes. The
resulting PER and CRY proteins then form complexes that
translocate into the nucleus and inhibit transcription of their
own genes by interacting with CLOCK and BMAL1. Post-
translational modification, for example by phosphorylation of
PER by CSNK1e and CSNK1d, regulates the stability and activity
of clock proteins and is amajor determinant of the periodicity of
the molecular feedback loop [10].
The core molecular loop is thought to interlink with
numerous secondary loops that enable it to interact with other
aspects of cell physiology and metabolism. One such
‘‘secondary loop’’ involves the nuclear receptors NR1D1
(REVERBa) and NR1D2 (REVERBb). The clock regulates the
expression of both of these nuclear receptors, whereas their
encoded proteins act to inhibit BMAL1 transcription, thus
providing temporal control of the core loop, as well as
regulating the circadian expression of thousands of other
genes,manyassociatedwithmetabolism. TheNR1Ds/REVERBs
also drive the circadian recruitment of the deacetylase HDAC3,
thus regulating the rhythmic modification of chromatin and
consequent repression of transcription at REVERB binding
sites [11, 12]. The clock has many other molecular links with
cellular metabolism and responds to the metabolic state of the
cell. For example, NADþ/NADH redox equilibrium is detected
via direct binding of these metabolites to CLOCK or NPAS2 and
therebymodulatingDNAbindingof theCLOCK(NPAS2)/BMAL1
heterodimer [13]. Cellular redox state can also be sensed by the
REVERBs via heme binding, which enhances their interaction
with the co-repressors NCOR1 and HDAC3, thus regulating
circadian transcription [14].
Using our own algorithm, we have previously analyzed
transcriptomic data from human blood cells to identify genes
that have a prevalent circadian expression profile in four
separate conditions [2, 7]. Thus, we assess each individuals’
time-series separately to identify transcripts that are frequently
observed, with a false discovery rate of less than 5%, to have a
significant oscillatory component. Clearly, if we analyze and/or
visualize the averaged (across subjects) transcriptomic profiles,
where there is a dependency on expression value congruency
between subjects, and/or change our selection thresholds,
different results may be produced/observed.
When sleep and the body clock are
synchronized, 6.4% of genes in blood are
rhythmic
Under baseline conditions of sleeping in phase with the
melatonin rhythm, 1,396 genes were characterized as having a
circadian expression profile (Fig. 1A, Supplemental Table 1).
These included the majority of the core circadian clock genes
(Table 1). Gene ontology (GO) analysis using the online tool
WebGestalt [15, 16] with default parameters and the human
genome as background, showed that these genes with a
circadian expression profile were associated with biological
processes that mainly relate to the regulation of transcription
and translation (Fig. 1A).
One week of insufficient sleep reduces the
number of rhythmic transcripts by 20%
During40hoursof TSDafter either 1weekof sufficient sleep (ca.
8.5hours per night) or after 1week of insufficient sleep (ca.
5.7 hours per night), there were similar numbers [1,855 (8.8%)
and 1,481 (6.9%), respectively] of genes with a circadian
expression profile (Fig. 1B and C). In both of these conditions,
themajorityof thecorecircadianclockgeneswerealso rhythmic
(Table 1). However, unlike when sleeping in phase with
melatonin (i.e. in phase with the central hypothalamic clock),
genesthatwererhythmic inbothof theseconditionsofTSDwere
associated with blood-related, day-active biological processes
that included immune response, defence response, leukocyte
activation, and T cell activation.
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Figure 1. Number of genes with a circadian expression profile identified for each of the four sleep conditions; A: sleeping in phase with
melatonin; B: during acute sleep deprivation after sufficient sleep; C: during acute sleep deprivation after insufficient sleep; D: sleeping out of
phase with melatonin). Cartoons indicate when sleep (S) and wake (W) occurred with respect to biological day (sun) and biological night
(moon). For each condition, numbers in brackets indicate the number of rhythmic core clock genes. The top-ten biological processes
associated with the genes with a circadian expression profile identified in each comparison listed above, respectively. The % enrichment for
each process is listed together with the p-value. The colour-coded pie chart segments also represent the % enrichment for each process.
E. E. Laing et al. Prospects & Overviews....
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Only 1% of blood genes are rhythmic
when sleep occurs out of phase with the
body clock
When sleep occurred out of phase with melatonin,
only 228 (1%) genes remained rhythmic, including
only three core clock genes (NR1D1, NR1D2, and
CSK1e) (Fig. 1D). With this reduced number of
rhythmic genes, none of the GO terms identifiedwere
significant but the top-ten were related to some
blood-specific functions (Fig. 1D).
826 rhythmic genes are invulnerable to
one week of sleep loss
Following the description of genes with rhythmic
expression in each of the four experimental
conditions (Fig. 1), we next assessed rhythmic genes
common to different conditions (Fig. 2). In total, 826
genes (Supplementary Table 1) were found to have
a circadian rhythm during the 40 hours TSD,
irrespective of whether subjects had experienced
one week of sufficient or insufficient sleep (Fig. 2i).
Here the majority of the core circadian clock genes
were rhythmic, including: NR1D2 (Fig. 3), NR1D1
(Fig. 4), CSNK1e, ARNTL, NPAS2, PER1, PER2, PER3,
and RORA; CSNK1d was only rhythmic after 1week
of sufficient sleep, and CLOCK was only rhythmic
after 1week of insufficient sleep (Table 1). The top-
ten significant biological processes that are over-
represented in this gene list include: response to
wounding, immune response, defense response,
cytokine production, lymphocyte activation, and
T cell activation (Fig. 2i).
46 rhythmic genes are invulnerable to
desynchronized sleep
We then compared the conditions of sleeping in and
out of phase with melatonin, a perturbation with
substantial effects on rhythmicity within the human
transcriptome [2]. We found only 46 genes had a
circadian expression profile in both conditions
(Fig. 2ii, Supplementary Table 1). When sleeping
in phase with melatonin, transcripts with a rhythmic
expression profile included the core clock genes
NR1D2, CSNK1e, ARNTL, NPAS2, PER2, PER3, and
CRY2, whereas when sleeping out of phase only
NR1D2 (Fig. 3) and CSNK1e remained rhythmic while
NR1D1 became rhythmic (Fig. 4) (Table 1). Although
NR1D1 by our analytical approach is not statistically
characterized as circadian when sleeping in phase,
its expression profile nevertheless demonstrates
similarity to other temporal profiles (Fig. 4). The
top-ten biological processes that are over-repre-
sented in this gene list included: response to steroid
hormone stimulus, O-glycan processing, triglyceride
metabolic process, neutral lipid metabolic process,T
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response to corticosteroid stimulus, and the B cell receptor
signalling pathway (Fig. 2ii).
A core set of 28 genes remains rhythmic in blood
during all four sleep conditions
Despite significant physiological differences between the four
sleep conditions analyzed, in which the presence/absence of
sleep and also the timing of sleep relative to the central
circadian clock are investigated, 28 genes were identified as
being rhythmic across all conditions (Fig. 2iii; Table 2;
Supplementary Table 2). These ‘‘robust’’ circadian genes are
rhythmically expressed independently from the sleep/wake
cycle and must, at least in humans, constitute a central
component of circadian processes in blood. This list includes
only two canonical clock genes, namely NR1D2 and CSNK1e.
The top-ten, but not statistically significant, biological
processes over-represented in this robust circadian gene list
include: response to wounding, neuron projection regener-
ation, the B cell receptor signalling pathway, response
to glucocorticoid stimulus, sulfur compound biosynthetic
process, immune response-regulating cell surface receptor
signalling pathway, O-glycan processing, humoral immune
response, neutral lipid metabolic process, and response to
temperature stimulus.
The majority of the 28 robustly rhythmic genes
have peak expression during the biological day
Of the 28 genes we identify as rhythmic in all four human sleep
conditions, 23 had peak expression during the biological day,
i.e. when melatonin concentrations are very low, and only five
(NR1D2,HNRPDL,BCL2,MAL, andNELL2)hadexpressionpeaks
during the biological night. In agreement with our previous
data, the day-peaking robust genes were associated with
processes related to immune function and included response to
wounding, B cell receptor signalling, and humoral immune
response. Thus, the core set of robust circadian genes are
overwhelmingly expressed during the day and involved with
blood-specific immune responses. Of the five genes whose
expressionpeakduring thenight, twoare involvedwithbinding
to nucleic acid and regulating either transcription (NR1D2) or
translation (HNRPDL). HNRPDL (heterogeneous nuclear ribo-
nucleoprotein D-like) binds NRF (NFkb repressing factor)
mRNA either at the 50-untranslated region (50-UTR) leading to
increased translation initiation, or at its 30-UTRwhere it leads to
increased mRNA stability [17]. BCL2 is an anti-apoptotic factor
that forms part of the unfolded protein response within the
endoplasmic reticulum stress rheostat pathway by regulating
calcium flux and mitochondrial control of apoptosis [18]. MAL
(myelin and lymphocyte protein; T cell differentiation protein)
forms part of the protein machinery that transports membrane
and secretory proteins and is involved in membrane trafficking
and signalling in T cells [19]. NELL2 (neural epidermal growth
factor-like 2) plays a role in neuron differentiation but is also
expressed in nucleated blood cells where it may function to
regulate cell development [20]. In the brain, NELL2 has been
shown to regulate long-term potentiation (LTP) and hippo-
campus-dependent spatial learning inmice [21]. Therefore, this
small group of highly robust circadian night-peaking genes are
involved with the regulation of gene expression (in agreement
with our previous data), the trafficking of newly synthesized
proteins and responses to incorrect protein folding, and blood
cell development. Together, these biological day- and night-
peaking genes represent core processes whose rhythmicity at
the mRNA level remains insensitive to sleep loss and sleep
displacement.
Regulatory network driving expression of
robust circadian genes
Given the independence of our 28 robust circadian genes
from the sleep/wake cycle, it is of interest to investigate
signals that could drive or at least influence their rhythmic
expression. Based on analysis of current published data,
using MetaCoreTM (Thomson Reuters) and/or STRING (http://
string-db.org/), no direct interactions between the members
of our group of 28 human circadian genes and their products
are known. We therefore adopted two approaches to
investigate the putative regulatory networks that could be
created by looking at molecular interactions such as protein-
DNA (e.g. transcription factor binding) and/or protein-protein
interactions, directly upstream of the 28 genes, i.e. inter-
actions where one of the 28 genes (or their products) are
considered to be the target. To identify interactions, we used
the following criteria. The first approach employed the ‘‘build
network’’ tool in MetaCore. In the second approach we
interrogated the ENCODE Uniform ChIP-seq dataset via the
University of California Santa Cruz (UCSC) genome browser
(data last modified on April 12 2013). Five hundred and eighty-
four data files containing the genomic coordinates of binding
peaks for 161 transcription factors within different untreated
human cell lines were obtained. The peak coordinates were
compared with the 1,000 bp upstream regions of all genes
(also obtained from UCSC), and those genes with an upstream
region containing a transcription factor-binding peak were
classed as targets of that transcription factor.
Twenty-three of the 28 robust circadian genes had
upstream interactions documented withinMetaCore (accessed
May 11 2014). The network comprising these genes and their
upstream ‘‘interactors’’ consists of 14,649 interactions (note
that this number includes interactions between upstream
interactors). Focusing on the 516 interactions where the target
(as opposed to source) of an interaction was one of the robust
circadian genes, we discovered that no single upstream
element interacted with more than 6 of the 28 robust circadian
genes, suggesting that there are likely to be multiple ‘‘core’’
output pathways closely linked to the clock and relatively
insensitive to sleep. However, we did find nine upstream
elements that interacted with at least four (17%) of these
genes: estrogen receptor 1 (ESR1; six genes, 26%), UBIQUITIN
(six genes, 26%), cyclic AMP response element binding
protein 1 (CREB1; five genes, 22%), TIF1B (five genes, 22%),
OCT3/4 (four genes, 17%), CJUN (four genes, 17%), SP1 (four
genes, 17%), CMYC (four genes, 17%), and GCRA (four genes,
17%).
E. E. Laing et al. Prospects & Overviews....
548 Bioessays 37: 544–556, 2015 The Authors. Bioessays published by WILEY Periodicals, Inc.
P
ro
b
le
m
s
&
P
a
ra
d
ig
m
s
Figure 2. Venn diagram depicting the overlap of the lists of genes with a circadian expression profile obtained from analysis of gene
expression profiles in each of the four sleep conditions tested using our previously reported algorithm [2, 7]. Orange plus yellow highlighted
area indicates genes that are identified as having a circadian expression profile during 40 hours of wakefulness with and without sufficient
sleep. Blue and yellow highlighted area indicates genes that are identified as having a circadian expression profile when sleeping in and out
of phase with melatonin. Yellow area indicates genes that are found to have a circadian expression profile across all conditions we have
tested in humans, i–iii. Top-ten biological processes associated with the circadian genes identified in each comparison listed above,
respectively. Letters indicate which segments of the Venn contributed to the comparison. The total number of circadian genes identified is
given together with the number of rhythmic core clock genes (in brackets). The % enrichment for each process is listed together with the
p-value. The colour-coded pie chart segments also represent the % enrichment for each process.
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Six of the core rhythmic genes interact with
estrogen receptor 1
Twoof thesenineupstreamelementsareworthyofmoredetailed
discussion, due to their known links with circadian physiology.
Six of the core rhythmic genes (BCL2, NELL2, SLC6A6, DAAM2,
OCTN1,ADM) have direct interactionswith ESR1. ESR1 has been
shown to regulate sex-specific circadian behavior in mice.
Female mice have greater levels of activity than males but this
difference is absent in Esr1 knock out animals [22]. Female Esr1
knock-out mice also have a smaller phase shift in response to a
light pulse in the subjective night and this difference is absent in
Esr1 knockout mice [23]. In our forced desynchrony protocol,
ESR1was down regulated andwas themost connected node in a
direct interaction network of genes that showed amain effect of
sleep condition [2].ESR1wasalso themost connectednode in an
interaction network constructed from genes that showed
differential promoter methylation in shift workers [24]. Thus,
ESR1 shows consistent links with pathways that are associated
with, and are affected by manipulations of sleep-wake activity.
Multiple factors interact to determine circadian
expression
It may seem counter intuitive that ESR1 is down regulated
during mistimed sleep but shows interaction with six of the
core circadian genes. We can only speculate on how ESR1
influences the expression of these genes. ESR1 expression is
down regulated with mistimed sleep but the transcriptional
repressors NCOR1 and REST that regulate ESR1 mediated gene
expression are more down regulated during mistimed sleep
and specifically during the day [2]. Thus, overall levels of gene
expression driven by ESR1 could be higher. However, several
factors can interact to determine the overall expression
profiles of circadian genes. We have previously modeled the
interaction between positive or negative drives from melato-
nin and sleep, which can then predict the expression profiles
of transcripts when sleep occurs in or out of phase with
melatonin [2]. For example, if the expression of a circadian
gene is suppressed by melatonin (peaks during the day) but
enhanced by sleep, the expression profile can be circadian
when sleep occurs in phase with melatonin but with reduced
amplitude compared to when sleep occurs out of phase with
melatonin. Indeed, several of the core circadian genes in our
previous analysis [2] fell into this category (e.g. SLC6A6 and
CSNK1E) and the majority of the core circadian genes in this
analysis do too.
Five of the core rhythmic genes interact with the
circadian entrainment mediator CREB
Of relevance to other known clock-related pathways, five
genes (CREB5, BCL2, HNRNPDL, GK, and DAAM2) have direct
interactions with the transcription factor CREB1. Light-
Figure 3. The z-scored mRNA expression level
(meanSEM across subjects) of NR1D2
(A_23_P302709) within human blood during our
investigations of A: chronic and acute sleep
loss, B: forced desynchrony. Shaded grey area
indicates the corresponding average (across
subjects) plasma melatonin profile. Horizontal
bars indicate wake (w) and sleep (s) periods.
The figure shows that the expression profile of
NR1D2 remains relatively unchanged in
response to both insufficient sleep (A) and
mistimed sleep (B) with a peak of expression
close to the peak of melatonin secretion.
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induced phosphorylation of CREB in the mouse SCN allows it
to bind to cAMP response element sites in the promoters of
Per1 and Per2, thus providing an entrainment signal for the
central circadian clock [25]. CREB is also an activity-dependent
transcription factor in the brain where levels in the cortex
are higher during wake than sleep and contribute towards
sustaining wakefulness [26]. In the periphery, CREB regulates
glucose homeostasis and gluconeogenesis in the liver [27], and
has multiple roles in the immune system, including regulation
of genes such as IL2, IL6, IL10, and TNFa, inhibition of NFkb,
regulating the proliferation and survival of T and B cells,
and the generation of regulatory T cells [28]. When CREB is
activated by phosphorylation, it interacts with its coactivator
proteins CREBBP (CREB binding protein) and EP300, which
stimulate transcription by modifying DNA through histone
acetylation. Rhythmic recruitment of CREBBP and EP300 has
been shown to play an integral part in the circadian regulation
of the mammalian transcriptome [29]. Related to this, it is
perhaps particularly relevant that one of the 28 robust
circadian genes is CREB5.
Our analyzes indicate that multiple upstream regulatory
pathways may drive the rhythmic expression of the most
robust circadian genes. Some of these pathways have been
reported by others, but it is likely that integrated circadian
gene expression requires the coordinated input of multiple
pathways, some of which may not have been previously
linked to circadian biology. Alternatively, it is possible that
the power of this analytical approach and the datasets used do
not allow the identification of more universal upstream
regulatory transcription factors. Lastly, circadian rhythmicity
in gene expression is highly tissue-specific: many genes
(43%) are rhythmic in at least one tissue [9] but perhaps only
certain elements of the core clock are robustly rhythmic across
many tissues.
Congruency of human and mouse
rhythmic gene expression signals
To identify circadian genes across different data sets that are
publicly available from the CIRCA database [8, 9], we used
the selection criteria of: at least one probe with a JTK q-value
and/or p-value<0.05 [4]. Using this threshold, we identified
1,111 unique genes identified as having a circadian expression
profile in the human bone tissue cell line U2OS. By examining
the recently added RNA-seq data sets comprising global
transcriptome measurements across 12 different mouse
tissues [1], we then identified 13,644 unique mouse genes
that had a circadian expression profile in at least one tissue
stored within the CIRCA database. We also analyzed the
circadian gene lists from human hair follicles (240 genes) [1],
post-mortem human brain tissue (916 genes in the dorso-
lateral prefrontal cortex) [5], and from two mouse sleep
deprivation studies in brain (1,654 genes in control sleep
condition and 340 genes in sleep deprivation condition) [6]
and liver (3,231 genes for control, and 2,461 genes for sleep
restriction) [3].
Figure 4. The z-scored mRNA expression level
(meanSEM across subjects) of NR1D1
(A_23_P420873) within human blood during our
investigations of A: chronic and acute sleep
loss, B: forced desynchrony. Shaded grey area
indicates the corresponding average (across
subjects) plasma melatonin profile. Horizontal
bars indicate wake (w) and sleep (s) periods.
The figure shows that the expression profile of
NR1D1 remains relatively unchanged in
response to both insufficient sleep (A) and
mistimed sleep (B) with a peak of expression
close to the peak of melatonin secretion.
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Most canonical clock genes are rhythmic across
most samples
Tenof the 13 canonical clockgenes listed inTable 1 areclassified
as having rhythmic expression profiles in at least 50% of all
samples from human and mouse. Several of these (NR1D1,
NR1D2, PER2, PER3, andARNTL) are rhythmic in over 90%of all
samples analyzed and thus represent the robust core of the
circadian molecular clockwork. If rhythmic genes are sorted
according to the percentage of all samples in which genes are
rhythmic (Supplemental Table 1), there are 32 genes that are
rhythmic in at least 52% of all human and mouse samples.
Within these 32, there are 10 canonical clock genes, two clock
output transcription factors (DBP and TEF), and the circadian
transcriptional repressor, BHLHE41 (DEC2). Some clock genes
appear to show species-specific rhythmicity; CRY1, CRY2, and
CLOCK are rhythmic in fewhuman samples but highly rhythmic
in themouse samples, whereasCSNK1e is rhythmic in 71%of all
human samples but only 13% of all mouse samples. By far the
largest effect of sleep disruption on clock gene expression
rhythms is seen when sleep was displaced by 12hours from the
biological clock, where only three clock genes remained
rhythmic (NR1D1, NR1D2, and CSNK1e) [2].
The core set of 28 robust human circadian genes
invulnerable to sleep disruption is blood-specific
Of the 28 human genes that remain rhythmic in blood across
the four different sleep conditions, only two (NR1D2 and
SLC6A6) are also rhythmic in at least 50% of the mouse
samples, and the majority are also not rhythmic in the
human hair, bone, and brain samples (Table 2). As mentioned,
these blood-specific genes are enriched with transcripts
that are associated with blood-specific immune functions.
Because genome-wide expression has not been measured in
mouse blood, future investigations will need to determine if
these also represent human-specific blood transcripts.
Similarly, the limited accessibility of human tissues could
influence data interpretation.
A subset of genes is circadian across the
majority of human samples
Four genes (NR1D2, B4GALT5, SLC6A6, and CSNK1e) were
circadian across all human sleep conditions and in at least one
other human data set. B4GALT5 (b-1, 4-galactosyltransferase)
transfers sugar moieties in the biosynthesis of glycans and
regulates the hedgehog signalling pathway that controls cell
development and proliferation [30]. SLC6A6 (solute carrier
family sixmember 6–neurotransmitter transporter; also called
TAUT) is a taurine transporter. Taurine does not become
incorporated into proteins but regulates many cellular
functions including cell volume, antioxidant defense, protein
stabilization, stress response, and immunomodulation
(see [31]). CSNK1e phosphorylates PER proteins and plays
an important role in the circadian clock. Its temperature-
insensitive activity can determine circadian period [10] and
its absence in CSNK1d-deficient cells abolishes circadian
rhythmicity [32]. However, CSNK1e is a key phosphorylating
enzyme that provides post-translational regulation of many
other important pathways. These include the WNT signaling
pathway important during development and cancer [33, 34],
the modulation of topoisomerase and DNA cleavage activity
[35], and the regulation of the binding activity of DNA
methyltransferase I [36]. The fact that CSNK1e functions in
a temperature-insensitive way may be relevant to why it,
and possibly other robust circadian genes, remains robustly
rhythmic during all four sleep conditions, including during
mistimed sleep, when the amplitude of core body temperature
is known to be reduced [37].
NR1D1 and NR1D2 are the two most rhythmic
genes across all human and mouse samples
Mapping gene names through the tool MadGene [38], we
found that 15 (65%, not including genes with no apparent
homolog) of the 28 human robust circadian genes had
identifiable homologs in mouse that were circadian in at least
one tissue. Of the four genes that were circadian in at least 71%
of all human tissues and sleep conditions, only two were also
highly rhythmic across mouse tissues and sleep conditions
[NR1D2 (100%) and SLC6A6 (50%)] (Table 2). Only one gene,
NR1D2, was found to be circadian across the majority of
human and mouse tissues (96%) and in all sleep conditions
(control, sleep restriction, andmistimed sleep in both humans
and mice) (Table 2, Fig. 3 and Supplementary Figure 1). The
related gene NR1D1 exhibited similarly robust circadian
rhythms, although without reaching statistical significance
in one of the human blood data sets. Nevertheless, when
genes are ranked according to the percentage of all samples
where they are rhythmic (Supplemental Table 1), NR1D1 and
NR1D2 are the highest ranking genes both being rhythmic in
96% of all human and mouse samples.
The functional roles of NR1D1 and NR1D2 within the
circadian clock have recently been identified. A role for NR1D1
within the mammalian clock machinery was proposed over
10 years ago [39]. More recent work with Nr1d1/Nr1d2 null
mice [12] and RNA silencing [40] now point to NR1D2 having a
more prominent and possibly more important cell type-
dependent role than previously thought. NR1D2 binds to
Reverb/Ror element (RRE) sites in promoter elements. Peak
binding occurring in mouse towards the end of the inactive
light phase, 10 hours after ‘‘lights-on’’ when NR1D2 gene
expression is highest [12, 41]. In our human data, peak NR1D2
gene expression also occurred towards the end of the
biological night. The majority of the NR1D2 genomic binding
sites overlap with those of NR1D1 and many are also shared
with the BMAL1 cistrome and promoter recruitment sites for
the nuclear receptor corepressor (NCOR1) and the histone
deacetylase (HDAC3) transcriptional repressor complex [12,
41]. Thus, NR1D2/NR1D1 together with NCOR1/HDAC3
can suppress the transcription of Bmal1 and genes whose
expression is activated by BMAL1. Promoter regions that bind
NR1D2/NR1D1 are located in genes that are predominantly
associated with primary metabolic processes, lipid metabo-
lism, PPAR signalling, protein metabolic processes, and
nucleic acid metabolic processes [12, 41].
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The reasonwhyNR1D1andNR1D2areat the topof ranked lists of
rhythmic genes is unclear. We speculate that the ranking likely
reflects the position of NR1D1 and NR1D2 and the interface of
the circadian transcription-translation loops and metabolic
rhythms. Indeed, in liver-specific knockdowns of both Nr1d1
and Nr1d2 in mice, more than 90% of genes whose
expression is circadian lose rhythmicity, and animals
display increased circulating glucose and triglyceride
levels, and reduced levels of free-fatty acid [41]. Given
the obvious importance of metabolism to cell and
organismphysiology,we therefore contendthatNR1D2,
possibly acting with NR1D1, provides robust time-
keeping for key metabolic processes, and protects
against state manipulations, such as changes in the
occurrence and timing of sleep. Furthermore, other
canonical circadian genes (e.g. PER3, ARNTL, PER2,
PER1;Table1)exhibit similar rhythmicity,albeit slightly
less prominent than NR1D1 and NR1D2. The independ-
ent finding by ourselves and others [9] that NR1D1 and
NR1D2 are the most rhythmic genes indicates that the
rhythmic function of the overall circadian clockwork
is not only a feature of multiple tissues, but also
remarkably resilient to sleep manipulations.
Rhythmic genes affected by sleep
disruption point towards mechanisms that
underlie associated adverse health
outcomes
Analysis of variance for the expressionprofilesof genes
in our two human-blood sleep studies showed that
there was a main effect of sleep condition in 744
transcripts when comparing sufficient and insufficient
sleep [7] and for 1,119 transcripts comparing sleep in
phase and sleep out of phasewithmelatonin [2]. Using
MetaCoreTMwe performed a direct interaction network
analysis on these two gene sets. This analysis connects
elements that are known to interact at the gene or
protein level. Major nodes within each interaction
network are labelled, and node size indicates level of
connectivity, while node colour indicates associated
GO terms (Fig. 5). The interaction network for the
ANOVAmaineffect of sleeping inoutofphasewithmelatonin is
shown in Fig. 5A, and for the main effect of sufficient or
insufficient sleep in Fig. 5B. The greater disruption caused by
sleeping out of phase with melatonin is reflected by a larger
number of interacting elements (Fig. 5A). Many of these
Figure 5. Direct interaction networks, as documented by
MetaCoreTM, between genes for which at least one tran-
script had a statistically significant main effect of sleeping
in-phase and out-of-phase with melatonin (A), or a main
effect one week of either sufficient or insufficient sleep prior
to a 40hours period of total sleep deprivation (B). Node
size reflects the number of direct connections a gene has
within the network. Node color (see key) represents the
most significantly enriched GO biological process term
associated with that node given the submission of the
statistically significant gene lists to the tool WebGestalt. The
figures identify networks of genes that are affected by sleep
disruption that also show high levels of interactivity. Some
interacting genes are common to both sleep disruption
conditions, and a large number are linked with processes
known to be associated with adverse health outcomes (see
text for details).
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interaction nodes are associated with adverse health pheno-
types: CUX1 repairs DNA oxidative damage and is a tumour
suppressor [42, 43], REL and NFKB2 are part of the NFKB
signalling pathway and associated with immune function and
cancer [44, 45]; REST is a transcriptional repressor linked with
prostate cancer and regulates cardiac gene expression [46, 47];
EP300 is a transcriptional co-activator that regulates circadian
gene expression and ESR1-stimulated expression and is linked
with prostate cancer [29, 48]; IL6, and MAPK11 are linked with
immune function and cancer [49, 50]; PIK3CA and PIK3R1 are
linked with insulin resistance, immune response and can-
cer [51–53], PPARA is associated with lipid homeostasis,
inflammation, and type-2 diabetes [54–56], MLL is a methyl-
transferase that regulates circadian gene expression and is
linkedwith cancer [57, 58], and ESR1 regulates gene expression
and is associated with cancer [59, 60]. An overlapping set of
interacting genes are affected by both sleep restriction
and mistimed sleep: MLL, CSNK1e, MAP kinase transcripts
(MAPK11,MAPK12,MAPK13),HSPA5,REST,NCOR1, IL6,MED1,
and RORA. Of interest, some of these genes and others in the
interaction networks are intimately involved in the regulation
of the RNA polymerase II transcriptional complex. MED1
forms a pivotal element of the RNA polymerase II Mediator
complex [61]. It interacts directly with thyroid, estrogen, and
glucocorticoid receptor elements in gene promoters [61]. The
Mediator complex activity is modulated by MAP kinase [62]
and DNA binding of the complex in promoter regions is
modulated by NCOR1, EP300, and REST [61, 63]. We have
previously shown that sleeping out of phase with melatonin
affects many biological processes and molecular functions
associated with the regulation of transcription and trans-
lation [2]. Here, the ANOVA main effect interaction networks
from both of our sleep disruption studies show how specific
elements that form an integrative regulatory hub for translation
are affected.Many of these elements have linkswith cancer and
MED1 has specific links with breast cancer [62]. Therefore, we
speculate that genes whose expression profiles become
dysregulated during disrupted sleep, as occurs when sleep is
displaced during shift work, point towards underlying bio-
logical processes that are linkedwith someof theadversehealth
outcomes associated with shift work, such as cancer and
metabolic disorders.
Conclusions and outlook
Resonance of robust, high-amplitude circadian rhythms with
behavioral cycles of sleep-wake and fasting-feeding are
important for lifelong well-being and health. Disruption to
these synchronized rhythms, as occurs in shift work and
ageing, leads to adverse health outcomes. Here, our results
demonstrate that comparative (meta) analyses of multiple
circadian transcriptomes provides novel insights into under-
lying circadian mechanisms. Furthermore, it will be useful to
include data from additional human tissues/cells and other
molecular technologies (e.g. proteomics, cistromics, and
metabolomics). Such analyzes would also be expected to
link disrupted circadian rhythms to negative health outcomes
such as metabolic disorders (obesity, type 2 diabetes),
cardiovascular disease, and cancer.
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